BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Press Releases

  Vistagen Initiates PALISADE-4 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder

  September 23, 2024

   · 

  8 min read
• Press Releases

  Capricor Therapeutics to Provide Duchenne Muscular Dystrophy Program Update on September 24, 2024

  September 23, 2024

   · 

  4 min read
• Press Releases

  Thryv Therapeutics to Participate in Fireside Chat During 2024 RBC Capital Markets Biotechnology Private Company Virtual Conference

  September 23, 2024

   · 

  1 min read
• Press Releases

  Therma Bright Investment Portfolio Company InStatin Secures Mountain West Research Discovery Study Agreement

  Clinical research will offer insight for specific targeting of active pharmaceutical ingredients (API) that will further support Phase 1 Human Trials

  September 23, 2024

   · 

  3 min read
• Press Releases

  Black Diamond Therapeutics to Host Webcast Presentation of Initial Phase 2 BDTX-1535 Data in Patients With Recurrent EGFRm NSCLC

  September 23, 2024

   · 

  1 min read
• Press Releases

  Sensorion Announces the Availability of its Half Year 2024 Report

  September 23, 2024

   · 

  3 min read
• Press Releases

  Angle PLC Announces Exclusive agreement for DNA NGS panel

  September 23, 2024

   · 

  6 min read
• Press Releases

  Medincell’s Partner Teva Presented New Efficacy, Safety, and Tolerability Data from Pivotal Phase 3 of Olanzapine LAI for Adult Patients Diagnosed with Schizophrenia

  September 23, 2024

   · 

  2 min read
• Press Releases

  Samsung Bioepis Presents Totality-of-the-Evidence Supporting Extrapolation of EPYSQLI™ (SB12; Eculizumab)’s Indication, at the European Society of Paediatric Nephrology (ESPN) 2024

  September 23, 2024

   · 

  7 min read
• Press Releases

  Zevra’s MIPLYFFA™ (arimoclomol) Receives Approval from U.S. Food and Drug Administration for Use in Patients with Niemann-Pick Disease Type C (NPC)

  September 23, 2024

   · 

  4 min read